Platform for Change and Improved Patient Experience

11:05 - 11:40

The enFuseTM platform, an on-body drug delivery system, is a unique technology being developed for patient self-administration of high-volume biologic drugs from 5 - 50mL. The system is designed with novel features to provide comfort, convenience and simplicity for the patient.  Some of these unique features will be discussed in terms of their impact on patients, drug development and the overall healthcare landscape.

Mike Hooven, President and CEO, Enable Injections, Inc.